# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-076528
Filing Date
2026-02-26
Accepted
2026-02-26 16:03:42
Documents
110
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | rgen-20251231.htm iXBRL | 10-K | 4650022
2 | EX-10.15 | rgen-ex10_15.htm | EX-10.15 | 272902
3 | EX-21.1 | rgen-ex21_1.htm | EX-21.1 | 23703
4 | EX-23.1 | rgen-ex23_1.htm | EX-23.1 | 7039
5 | EX-31.1 | rgen-ex31_1.htm | EX-31.1 | 13920
6 | EX-31.2 | rgen-ex31_2.htm | EX-31.2 | 13912
7 | EX-32.1 | rgen-ex32_1.htm | EX-32.1 | 17916
8 | GRAPHIC | img3344002_0.jpg | GRAPHIC | 420335
| Complete submission text file | 0001193125-26-076528.txt |  | 23694459

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rgen-20251231.xsd | EX-101.SCH | 2749937
113 | EXTRACTED XBRL INSTANCE DOCUMENT | rgen-20251231_htm.xml | XML | 5374869

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14656 | Film No.: 26687700
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)